STAT3 expression, activity and functional consequences of STAT3 inhibition in esophageal squamous cell carcinomas and Barrett's adenocarcinomas.
about
Analyzing and interpreting genome data at the network level with ConsensusPathDBAfrican-American esophageal squamous cell carcinoma expression profile reveals dysregulation of stress response and detox networks.STAT3 is involved in miR-124-mediated suppressive effects on esophageal cancer cells.Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling.Shp2 Inhibits Proliferation of Esophageal Squamous Cell Cancer via Dephosphorylation of Stat3ATM mutations and E-cadherin expression define sensitivity to EGFR-targeted therapy in colorectal cancer.Knockdown of long non-coding RNA HOTAIR increases miR-454-3p by targeting Stat3 and Atg12 to inhibit chondrosarcoma growth.Molecular interplay of pro-inflammatory transcription factors and non-coding RNAs in esophageal squamous cell carcinoma.Inhibition of glycogen synthase kinase 3 beta (GSK3β) suppresses the progression of esophageal squamous cell carcinoma by modifying STAT3 activity.Response of esophageal cancer cells to epigenetic inhibitors is mediated via altered thioredoxin activity.Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and AzacytidineSubcellular localization of EGFR in esophageal carcinoma cell lines.Apatinib promotes autophagy and apoptosis through VEGFR2/STAT3/BCL-2 signaling in osteosarcoma.Metformin inhibits esophageal squamous cell carcinoma-induced angiogenesis by suppressing JAK/STAT3 signaling pathway.Constitutive activated STAT3 is an essential regulator and therapeutic target in esophageal squamous cell carcinoma.Epigenomic characterization of a p53-regulated 3p22.2 tumor suppressor that inhibits STAT3 phosphorylation via protein docking and is frequently methylated in esophageal and other carcinomas.A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.
P2860
Q27887656-3E84168B-43FA-4A47-A04A-8595CA9C9174Q33814348-6EE35C9D-95AE-42A9-ADC1-5FA23FBF7E58Q35619400-6DA9C9C2-1A28-46EA-980E-169A17F48BDDQ37620713-E9062AEA-594E-4DAA-A01E-5754B983FA72Q37631584-66EF0A7C-3F83-48E3-AD63-A675B782AA8AQ37725589-05D8D34E-1937-4B56-A423-7D0F3575A364Q37745219-267326D9-BE92-42AB-B2F4-184CDC770170Q38670580-14479188-364B-404A-84AD-3FE51EE24E41Q38748837-10443E5F-DA19-4A93-A94B-98D8F14E518AQ38809883-5E8A00E5-FD30-4AAD-AFE9-126D48CEF56EQ38881033-B27E9B34-3988-4320-8914-53F0E0C0F3E3Q40784649-5D7E4A58-BCBC-4E4F-90D8-F31AC845C20FQ41167283-5412F953-6609-4F85-83AA-3D5DF7552A09Q43122698-A31FD6EC-6A21-4655-A244-74B1A894777FQ45850370-EEC43FD9-8286-400C-B5D1-68955E7CD7EEQ47103555-D20BFCD5-D73A-4F73-9466-381116560100Q47757344-0FE6E6D9-D713-4A63-9086-A59AE7C39721
P2860
STAT3 expression, activity and functional consequences of STAT3 inhibition in esophageal squamous cell carcinomas and Barrett's adenocarcinomas.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
STAT3 expression, activity and ...... and Barrett's adenocarcinomas.
@en
STAT3 expression, activity and ...... and Barrett's adenocarcinomas.
@nl
type
label
STAT3 expression, activity and ...... and Barrett's adenocarcinomas.
@en
STAT3 expression, activity and ...... and Barrett's adenocarcinomas.
@nl
prefLabel
STAT3 expression, activity and ...... and Barrett's adenocarcinomas.
@en
STAT3 expression, activity and ...... and Barrett's adenocarcinomas.
@nl
P2093
P2860
P356
P1433
P1476
STAT3 expression, activity and ...... and Barrett's adenocarcinomas
@en
P2093
A Schöpflin
C D Fichter
D Hauschke
D Klimstra
K Atanasov
L Bogatyreva
P2860
P2888
P304
P356
10.1038/ONC.2013.298
P407
P577
2013-08-05T00:00:00Z